The Mystery Of Russia’s COVID-19 Vaccine

Reports Differ Over Immunization Program & Manufacturing

Russia may have approved the first COVID-19 vaccine, but there is uncertainty over when immunization will begin, who will receive it first, and whether the Russian authorities are planning to carry out Phase III trials. 

Russia map close up with magnifier
Russia's COVID-19 vaccine approval has raised a lot of questions • Source: Shutterstock

Confusion is growing around Russia’s intentions for immunizing its population with the COVID-19 vaccine that the country approved on 11 August on the basis of Phase I/II studies.

Government representatives have said vaccination of at-risk groups such as doctors will begin shortly, and that a mass immunization program...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography